A first-in-human study of a novel monoclonal antibody INCSHR01210 directed against programmed cell death protein 1 (PD-1) in patients with advanced or metastatic cancer

J. Lickliter; Hui K. Gan; B. Gao; P. Grimison; J. Zou; H. Kallender; K. Sun; X. Chen; A. Behren; P. Fernandez-Penas; A. Nagrial; M. Voskoboynik; K. Woods; M. Millward; T. Meniawy

A first-in-human study of a novel monoclonal antibody INCSHR01210 directed against programmed cell death protein 1 (PD-1) in patients with advanced or metastatic cancer

J. Lickliter, Hui K. Gan, B. Gao, P. Grimison, J. Zou, H. Kallender, K. Sun, X. Chen, A. Behren, P. Fernandez-Penas, A. Nagrial, M. Voskoboynik, K. Woods, M. Millward, T. Meniawy

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

Original language	English
Number of pages	1
Journal	Annals of Oncology
Volume	28
Publication status	Published - Sept 2017
Externally published	Yes
Event	42nd European-Society-for-Medical-Oncology Congress (ESMO) - Madrid, Spain Duration: 8 Sept 2017 → 12 Sept 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Lickliter, J., Gan, H. K., Gao, B., Grimison, P., Zou, J., Kallender, H., Sun, K., Chen, X., Behren, A., Fernandez-Penas, P., Nagrial, A., Voskoboynik, M., Woods, K., Millward, M., & Meniawy, T. (2017). A first-in-human study of a novel monoclonal antibody INCSHR01210 directed against programmed cell death protein 1 (PD-1) in patients with advanced or metastatic cancer. Annals of Oncology, 28.

@article{8f397262012c46a9ba131b1c8925fdcd,

title = "A first-in-human study of a novel monoclonal antibody INCSHR01210 directed against programmed cell death protein 1 (PD-1) in patients with advanced or metastatic cancer",

author = "J. Lickliter and Gan, {Hui K.} and B. Gao and P. Grimison and J. Zou and H. Kallender and K. Sun and X. Chen and A. Behren and P. Fernandez-Penas and A. Nagrial and M. Voskoboynik and K. Woods and M. Millward and T. Meniawy",

year = "2017",

month = sep,

language = "English",

volume = "28",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

note = "42nd European-Society-for-Medical-Oncology Congress (ESMO) ; Conference date: 08-09-2017 Through 12-09-2017",

}

Lickliter, J, Gan, HK, Gao, B, Grimison, P, Zou, J, Kallender, H, Sun, K, Chen, X, Behren, A, Fernandez-Penas, P, Nagrial, A, Voskoboynik, M, Woods, K, Millward, M & Meniawy, T 2017, 'A first-in-human study of a novel monoclonal antibody INCSHR01210 directed against programmed cell death protein 1 (PD-1) in patients with advanced or metastatic cancer', Annals of Oncology, vol. 28.

TY - JOUR

T1 - A first-in-human study of a novel monoclonal antibody INCSHR01210 directed against programmed cell death protein 1 (PD-1) in patients with advanced or metastatic cancer

AU - Lickliter, J.

AU - Gan, Hui K.

AU - Gao, B.

AU - Grimison, P.

AU - Zou, J.

AU - Kallender, H.

AU - Sun, K.

AU - Chen, X.

AU - Behren, A.

AU - Fernandez-Penas, P.

AU - Nagrial, A.

AU - Voskoboynik, M.

AU - Woods, K.

AU - Millward, M.

AU - Meniawy, T.

PY - 2017/9

Y1 - 2017/9

M3 - Abstract/Meeting Abstract

SN - 0923-7534

VL - 28

JO - Annals of Oncology

JF - Annals of Oncology

T2 - 42nd European-Society-for-Medical-Oncology Congress (ESMO)

Y2 - 8 September 2017 through 12 September 2017

ER -